Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Coronado Research Appoints Nick Littlebury EVP, Regulatory Affairs
Breaking News, Promotions & Moves

Coronado Research Appoints Nick Littlebury as EVP of Regulatory Affairs

He previously led regulatory groups in the UK and Europe, overseeing the development and execution of global client solutions.

Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Littlebury is a senior regulatory leader with strategic and operational experience across the pharmaceutical industry’s product lifecycle.

Coronado Research CEO Andrew MacGarvey said, “His focus on cross-functional collaboration will enable integrated delivery solutions for our clients. He can draw on experience from positions within the Sponsor, Regulatory Authority, and service provision spaces to build optimised solutions for our customers.”

 He has previously led regulatory groups in the UK and Europe and has been responsible for developing and executing global client solutions focusing on innovation.

Littlebury commented, “Andrew has assembled an industry-leading team that provides best-in-class solutions across clinical development, market access, medical affairs, and regulatory, integrating technology expertise to optimize the drug development pathway. Artificial Intelligence (AI) and automation advancements are reshaping how we work. We will support companies in unlocking the full potential of these technologies to reduce regulatory burden, helping them focus on what matters most – the patient.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters